Publikationen von H. Urlaub
Alle Typen
Konferenzbeitrag (26)
441.
Konferenzbeitrag
92 (Suppl), P1.1-006, (2019)
Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, 04. Mai 2019 - 10. Mai 2019. Neurology 442.
Konferenzbeitrag
78 (13), 2692, (2018)
Elucidation of the pre-B-cell receptor signaling network in acute lymphocytic leukemia cells. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, 14. April 2018 - 18. April 2018. Cancer Research 443.
Konferenzbeitrag
39 (Suppl.), S. 219 - 219 (2016)
Elucidation of tonic and activated B cell receptor signaling in Burkitt's lymphoma reveals insights into non-oncogene addiction. Oncology Research and Treatment 444.
Konferenzbeitrag
101 (Suppl. 1), S. 166 - 166 (2016)
A novel epigenetic resistance mechanism to the FLT3 inhibitor PK412 induces cross-resistance to standard chemotherapy in acute myeloid leukemia (AML). 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 09. Juni 2016 - 12. Juni 2016. Haematologica 445.
Konferenzbeitrag
101 (Suppl. 1), S. 45 - 45 (2016)
Identification of novel B cell receptor antigens in chronic lymphocytic leukemia. 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 09. Juni 2016 - 12. Juni 2016. Haematologica 446.
Konferenzbeitrag
27, P1666, (2016)
Engineering nanobodies for super-resolution imaging and native protein complex isolation. Annual Meeting of the American Society for Cell Biology (ASCB), San Francisco, CA, 03. Dezember 2016 - 07. Dezember 2016. Molecular Biology of the Cell 447.
Konferenzbeitrag
126 (23), 2453, (2015)
Phosphoproteomic profiling of the signaling output of FLT3-ITD and its AC220-resistant mutants reveals profound signaling differences and differential responsiveness to inhibition of downstream kinases. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, 05. Dezember 2015 - 08. Dezember 2015. Blood 448.
Konferenzbeitrag
126 (23), (2015)
Identification of B cell receptor antigens in the chronic lymphocytic leukemia microenvironment. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, 05. Dezember 2015 - 08. Dezember 2015. Blood 449.
Konferenzbeitrag
10 (Suppl. 2), 9 Aufl., S. S293 - 293 (2015)
Proteomic profiling of pulmonary cancer with squamous cell histology. Journal of Thoracic Oncology 450.
Konferenzbeitrag
75 (Suppl. 15), 50, (2015)
Elucidation of B cell receptor signaling in Burkitt's lymphoma reveals novel signaling nodes with potential therapeutic relevance. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 18. April 2015 - 22. April 2015. Cancer Research 451.
Konferenzbeitrag
282 (Suppl. 1), S. 209 - 210 (2015)
Sequestering and protein cofactor competition regulate a multifunctional RNA helicase in different pathways. 40th Congress of the Federation of European Biochemical Societies (FEBS) - The Biochemical Basis of Life, Berlin, 04. Juli 2015 - 09. Juli 2015. FEBS Journal 452.
Konferenzbeitrag
15 (Suppl. 1), S. S226 - S227 (2015)
Elucidation of B cell receptor signaling in Burkitt's lymphoma reveals novel signaling nodes with potential therapeutic relevance. Twentieth International Hematologic Malignancies 2014 Conference. Clinical Lymphoma Myeloma and Leukemia 453.
Konferenzbeitrag
100 (Suppl. 1), S. 178 - 178 (2015)
The B cell reseptor signaling output in Burkitt´s lymphoma is genotype specific and impacts sensitivity towards BCR signaling inhibitors. 20th Congress of the European Hematology Association , Vienna, Austria, 11. Juni 2015 - 14. Juni 2015. Haematologica 454.
Konferenzbeitrag
25, S. E57 - E57 (2014)
Exploring the complete spectrum of CRM1 cargoes. ASCB/IFCB Meeting, Philadelphia, PA, 06. Dezember 2014 - 10. Dezember 2014. Molecular Biology of the Cell 455.
Konferenzbeitrag
74 (Supplement S), 2487, 19 Aufl., (2014)
Comprehensive quantitative proteomic profiling of lung cancers reveals novel biomarkers and potential drug targets. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, 05. April 2014 - 09. April 2014. Cancer Research 456.
Konferenzbeitrag
37 (Suppl. 5), S. 225 - 226 (2014)
Syk and Btk induce cell survival and proliferation in AML cells by activating distinct signaling pathways and transcriptional programs. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, 14. Oktober 2014 - 16. Oktober 2014. Oncology Research and Treatment 457.
Konferenzbeitrag
74 (Supplement S), 4203, 19 Aufl., (2014)
A transducer module consisting of Toll-like receptor 9 and Bruton's tyrosine kinase triggers acute myeloid leukemia blast proliferation. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, 05. April 2014 - 09. April 2014. Cancer Research 458.
Konferenzbeitrag
124 (21), (2014)
Syk and Btk transduce survival and proliferation-inducing signals by activating distinct signaling pathways and transcriptional programs in AML cells. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06. Dezember 2014 - 09. Dezember 2014. Blood 459.
Konferenzbeitrag
73 (Supplement 1), 1107, (2013)
β2 integrin–derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 06. April 2013 - 10. April 2013. Cancer Research 460.
Konferenzbeitrag
26 (Supplement 2), S. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders